Pfizer/BioNTech show high immune response in a booster dose against Omicron in clinical trial for children 5-11 years

Article

Pfizer/BioNTech announce positive results for a third dose of their COVID-19 vaccine for children

Grant Paulsen, MD, assistant professor, Division of Infectious Disease, Department of Pediatrics, Cincinnati Children's Hospital Medical Center in Ohio, and primary investigator for the hospital's clinical trial for a third dose (booster) for the Pfizer/BioNTech vaccine for COVID-19, discusses what the data might mean for children aged 5 to 11 years.

Recent Videos
Suzanne Hollander, MS, RD, LDN, Senior Clinical Nutrition Specialist, Boston Children's Hospital | Image credit: Boston Children's
Jillian Cotter, MD
Decreasing antibiotics for acute otitis media and community acquired pneumonia, with Elysha Pifko, MD
Tina Tan, MD
Danielle Van Damme, DNP, CPNP-AC
Karen Y. Capusan, DNP, CPNP-PC
Measles outbreaks: 223 cases reported in Texas | Donna Hallas, PhD, PPCNP-BC, CPNP, PMHS, FAANP, FAAN
Mary Koslap-Petraco, DNP, PPCNP-BC, CPNP, FAANP
Related Content
FDA approves Jivi for patients aged 7 years and older with hemophilia A | Image credit: Contemporary Pediatrics

FDA approves Jivi for patients aged 7 years and older with hemophilia A

Joshua Fitch, Senior Editor
May 21st 2025
Article

The expanded indication follows original approval in August 2018 for use in previously-treated patients 12 years and older.

What's going on with polio, monkeypox, and COVID-19

What's going on with polio, monkeypox, and COVID-19

Miranda Hester
August 19th 2022
Podcast

The news is full of stories about monkeypox, the recent changes to COVID-19 guidance, and the return of polio cases. What do clinicians need to know?

Weekly review: Multiple FDA action items, USPSTF recommendation, and more

Weekly review: Multiple FDA action items, USPSTF recommendation, and more

Joshua Fitch, Senior Editor
May 19th 2025
Article

Get caught up with Contemporary Pediatrics! This list helps you navigate our top stories from the week, all in one place.

What Omicron could mean for the pandemic

What Omicron could mean for the pandemic

Miranda Hester
January 7th 2022
Podcast

Contemporary Pediatrics sat down with Tina Q. Tan, MD, FAAP, FIDSA, FPIDS, to discuss what's known about the variant. She also discusses the latest on the vaccine for children aged younger than 5 years.

RSV data highlight age- and condition-specific risks for severe disease in children | Image Credit: © bankrx - © bankrx - stock.adobe.com.

Age, condition-specific risks for severe RSV disease in children

Joshua Fitch, Senior Editor
May 17th 2025
Article

Severe RSV disease in 2022–2023 was most likely to occur in infants under 6 months and older children with pulmonary or neurologic conditions.

Data highlights motor function improvements with ELEVIDYS treatment | Image Credit: © Colored Lights - © Colored Lights - stock.adobe.com.

Duchenne muscular dystrophy gene therapy demonstrates improved motor functions

Joshua Fitch, Senior Editor
May 16th 2025
Article

Delandistrogene moxeparvovec-rokl (ELEVIDYS) showed significant motor function improvements in 8- to 9-year-old Duchenne muscular dystrophy patients in part 2 of the phase 3 EMBARK study.

© 2025 MJH Life Sciences

All rights reserved.